QC
NUVB icon

Quadrature Capital’s Nuvation Bio NUVB Stock Holding History

Quadrature Capital’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$660K Buy
+116,113
New +$568K 0.01% 903
2025
Q4 		– Sell
-124,437
Closed -$460K – 1541
2025
Q3 		$460K Buy
+124,437
New +$339K 0.01% 546

Other funds holding NUVB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.21B AUM 82.36% 1-Year Est. Return

Quadrature Capital's NUVB Position: Q2 2026 in Review

Quadrature Capital opened a new position in Nuvation Bio (NUVB) in Q2 2026: 116,113 shares worth $660K. The stake represents 0.01% of the portfolio and ranks #903 among its holdings. This is a return to the name: Quadrature Capital previously reported a position in NUVB as recently as Q3 2025.

Quadrature Capital first reported a position in NUVB in Q3 2025 and has held it in 2 quarters since. 87 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Quadrature Capital held 116,113 shares of Nuvation Bio worth $660K as of Q2 2026.
  • Nuvation Bio was a new Quadrature Capital position in Q2 2026.
  • Nuvation Bio made up 0.01% of Quadrature Capital's portfolio in Q2 2026, its #903 holding.
  • Quadrature Capital first reported a position in Nuvation Bio in Q3 2025 and has held it in 2 quarters since.
  • 87 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.